Vicarious Surgical
Vicarious Surgical Raises An Additional $13.2 Mil in Capital
Vicarious Surgical added Philip Liang and Ric Fulop to their Board of Directors.
Vicarious Surgical
Vicarious Surgical Announces Breakthrough Designation by the FDA
The FDA Breakthrough Devices Program is intended to help patients receive more timely access to breakthrough technologies that have the potential to provide more effective treatment.
